Lipid peroxidation and sarcopenia: molecular mechanisms and potential therapeutic approaches

Yifan Lu, Tiao Li, Shu Yang, Chengyin Lu, Zhiqiang Luo, Jingrui Wang, Hui Xiong, Wangyang LiFrontiers in Medicine 2025 · DOI

Abstract

Sarcopenia is an age-related condition characterized by the progressive loss of skeletal muscle mass and strength. With the global aging population, its incidence is rapidly increasing. Lipid peroxidation is a critical biochemical process that generates reactive oxygen species (ROS), leading to the destruction of muscle cell structure and function. It plays a pivotal role in the onset and progression of sarcopenia. This review summarizes the mechanisms by which lipid peroxidation contributes to sarcopenia, with a focus on its regulatory effects on cell membrane damage, mitochondrial dysfunction, and cell death. In addition, we discuss the protective role of antioxidant factors such as GPX4 (glutathione peroxidase 4) and antioxidant peptides like SS peptides in mitigating lipid peroxidation and delaying the progression of sarcopenia. Finally, the potential of various strategies, including natural compounds, supplements, natural extracts, and lifestyle interventions, in inhibiting lipid peroxidation and promoting muscle health is explored.

Introduction: The Sarcopenia Crisis

Sarcopenia is a burgeoning public health crisis, affecting up to 27% of the global elderly population and leading to increased falls, fractures, and mortality. While the general phenomenon of muscle loss with age is well-documented, the precise molecular "vicious cycles" that sustain it are complex.

This paper identifies lipid peroxidation (LPO)—the oxidative degradation of lipids—as a primary driver of sarcopenia. LPO is a free-radical-driven process that attacks polyunsaturated fatty acids (PUFAs) in cell membranes. Because muscle cells are highly active and rely heavily on intact membranes for electrical signaling and nutrient transport, they are particularly vulnerable. This review synthesizes current research to explain how LPO moves from a chemical reaction to a systemic cause of muscle atrophy.

Methodology

The authors conducted a comprehensive synthesis of 105 recent studies (up to early 2025) to map the relationship between LPO and sarcopenia. The evidence is categorized into three functional areas:

  1. Molecular Mechanisms: How LPO triggers membrane damage, mitochondrial dysfunction, and various forms of cell death (apoptosis, necrosis, and ferroptosis).
  2. Aggravating Factors: How genetics (e.g., ALDH2 mutations), denervation, and chronic diseases accelerate LPO.
  3. Therapeutic Interventions: A systematic evaluation of natural compounds, supplements, and lifestyle changes based on their ability to inhibit LPO.

Key Insights: Molecular Mechanisms of Decay

Lipid peroxidation initiates a cascade of cellular destruction that specifically targets the high metabolic activity of muscle cells.

  • The Vicious Cycle of the Membrane: LPO damages membrane proteins like the sodium-potassium pump and the calcium ATPase (SERCA). This leads to an influx of calcium ions, causing uncoordinated muscle contractions and further cellular destruction.
  • Mitochondrial "Waste" Accumulation: LPO products like 4-HNE and MDA inhibit mitophagy (the cleaning up of damaged mitochondria). These "waste" mitochondria stay in the cell, leaking even more reactive oxygen species (ROS), which triggers more LPO—a self-sustaining loop of decay.
  • GPX4 as the Master Regulator: Glutathione peroxidase 4 (GPX4) is identified as the essential "fire extinguisher" for LPO. GPX4 levels naturally decline with age, which may be the primary reason why elderly muscles lose their ability to defend against oxidative stress.
  • Ferroptosis in Muscle: The review highlights ferroptosis—an iron-dependent form of regulated cell death—as a major pathway for muscle fiber loss, suggesting that iron homeostasis is critical for muscle health.
  • Fast-Twitch Vulnerability: Fast-twitch muscle fibers, used for explosive power, appear more susceptible to LPO-induced damage than slow-twitch fibers, explaining why power often declines faster than endurance in the elderly.
Molecular pathways of lipid peroxidation and the regulatory role of GPX4 in muscle cells.

Aggravating Factors and Clinical Context

Several systemic factors can accelerate the LPO process. Genetic variations, such as ALDH2 mutations, lead to the accumulation of toxic aldehydes like 4-HNE. Other factors include denervation, nutritional deficiencies (e.g., Vitamin D and protein malnutrition), and chronic diseases like heart failure, all of which exacerbate muscle damage through increased lipid peroxidation.

Summary of factors and mechanisms contributing to lipid peroxidation-induced muscle atrophy.

Therapeutic Interventions

The paper provides a roadmap of potential interventions to mitigate muscle wasting:

  • Natural Compounds: Astaxanthin and Fucoxanthin show strong potential in reducing mitochondrial ROS. Quercetin helps reduce the expression of ubiquitin ligases, which tag muscle proteins for breakdown.
  • Targeted Peptides: SS peptides (Szeto-Schiller peptides) are highlighted for their ability to bind specifically to cardiolipin in the inner mitochondrial membrane, protecting the cell's powerhouse from the inside out.
  • Lifestyle Efficacy: Exercise training and electrical stimulation biochemically restore antioxidant enzyme activity and inhibit the Ubiquitin-Proteasome System (UPS), which otherwise aggressively degrades muscle tissue.

Limitations and Future Work

Despite these insights, several hurdles remain. There is currently no universally established diagnostic standard for sarcopenia, making early detection of LPO damage difficult. Furthermore, much of the molecular evidence regarding ferroptosis and GPX4 relies on animal models; large-scale human clinical trials are needed. The authors call for the development of dynamic, non-invasive biomarkers to monitor LPO levels in real-time, allowing for personalized "redox-targeted" therapies.

Summary updated

Abstract

Sarcopenia is an age-related condition characterized by the progressive loss of skeletal muscle mass and strength. With the global aging population, its incidence is rapidly increasing. Lipid peroxidation is a critical biochemical process that generates reactive oxygen species (ROS), leading to the destruction of muscle cell structure and function. It plays a pivotal role in the onset and progression of sarcopenia. This review summarizes the mechanisms by which lipid peroxidation contributes to sarcopenia, with a focus on its regulatory effects on cell membrane damage, mitochondrial dysfunction, and cell death. In addition, we discuss the protective role of antioxidant factors such as GPX4 (glutathione peroxidase 4) and antioxidant peptides like SS peptides in mitigating lipid peroxidation and delaying the progression of sarcopenia. Finally, the potential of various strategies, including natural compounds, supplements, natural extracts, and lifestyle interventions, in inhibiting lipid peroxidation and promoting muscle health is explored.
BibTeX
@inproceedings{lu2025lipid,
  author = {Yifan Lu and Tiao Li and Shu Yang and Chengyin Lu and Zhiqiang Luo and Jingrui Wang and Hui Xiong and Wangyang Li},
  title = {{Lipid peroxidation and sarcopenia: molecular mechanisms and potential therapeutic approaches}},
  booktitle = {Frontiers in Medicine},
  year = {2025},
  doi = {10.3389/fmed.2025.1525205},
}
Figure